Atika Capital Management LLC - Q1 2020 holdings

$522 Million is the total value of Atika Capital Management LLC's 252 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 177.3% .

 Value Shares↓ Weighting
AMZN BuyAMAZON COM INC$44,844,000
+188.9%
23,000
+173.8%
8.59%
+186.8%
XBI NewSPDR SER TRput$27,491,000355,000
+100.0%
5.27%
MSFT BuyMICROSOFT CORP$22,396,000
+44.9%
142,000
+44.9%
4.29%
+43.8%
RNG BuyRINGCENTRAL INCcl a$20,132,000
+70.5%
95,000
+35.7%
3.86%
+69.3%
EHTH BuyEHEALTH INC$18,306,000
+101.6%
130,000
+37.6%
3.51%
+100.1%
ZLAB BuyZAI LAB LTDadr$16,988,000
+43.3%
330,000
+15.8%
3.26%
+42.2%
INSP BuyINSPIRE MED SYS INC$16,214,000
-17.6%
269,000
+1.5%
3.11%
-18.2%
TMUS BuyT MOBILE US INC$14,431,000
+148.6%
172,000
+132.4%
2.77%
+146.7%
RETA BuyREATA PHARMACEUTICALS INCcl a$11,836,000
-7.4%
82,000
+31.2%
2.27%
-8.1%
ZM BuyZOOM VIDEO COMMUNICATIONS INcl a$11,690,000
+758.9%
80,000
+300.0%
2.24%
+751.7%
CTXS NewCITRIX SYS INC$10,050,00071,000
+100.0%
1.93%
COUP BuyCOUPA SOFTWARE INC$9,082,000
+15.0%
65,000
+20.4%
1.74%
+14.1%
RGEN BuyREPLIGEN CORP$9,007,000
+14.6%
93,300
+9.8%
1.73%
+13.7%
TNDM BuyTANDEM DIABETES CARE INC$8,687,000
+11.2%
135,000
+3.1%
1.66%
+10.4%
CTLT BuyCATALENT INC$8,259,000
+30.8%
159,000
+41.8%
1.58%
+29.9%
NVDA NewNVIDIA CORP$6,853,00026,000
+100.0%
1.31%
KRTX BuyKARUNA THERAPEUTICS INC$6,480,000
+17.8%
90,000
+23.3%
1.24%
+16.9%
ARGX BuyARGENX SEsponsored adr$6,455,000
-10.2%
49,000
+9.4%
1.24%
-10.9%
HRC NewHILL ROM HLDGS INC$6,217,00061,809
+100.0%
1.19%
DCPH NewDECIPHERA PHARMACEUTICALS IN$5,805,000141,000
+100.0%
1.11%
ICUI NewICU MED INCcall$5,246,00026,000
+100.0%
1.00%
DOCU NewDOCUSIGN INC$4,989,00054,000
+100.0%
0.96%
IOVA NewIOVANCE BIOTHERAPEUTICS INCcall$4,790,000160,000
+100.0%
0.92%
EXAS BuyEXACT SCIENCES CORP$4,698,000
-29.9%
81,000
+11.7%
0.90%
-30.5%
MELI NewMERCADOLIBRE INC$4,691,0009,600
+100.0%
0.90%
IRTC NewIRHYTHM TECHNOLOGIES INC$4,637,00057,000
+100.0%
0.89%
HEIA BuyHEICO CORP NEWcl a$4,613,000
-27.4%
72,200
+1.7%
0.88%
-28.0%
CI NewCIGNA CORP NEW$4,606,00026,000
+100.0%
0.88%
LOW BuyLOWES COS INC$4,561,000
-20.7%
53,000
+10.4%
0.87%
-21.3%
CVLT NewCOMMVAULT SYSTEMS INCput$4,048,000100,000
+100.0%
0.78%
ADBE NewADOBE INC$3,977,00012,500
+100.0%
0.76%
IOVA NewIOVANCE BIOTHERAPEUTICS INC$3,937,000131,500
+100.0%
0.75%
SAM NewBOSTON BEER INCcl a$3,896,00010,600
+100.0%
0.75%
CRWD NewCROWDSTRIKE HLDGS INCcl a$3,368,00060,500
+100.0%
0.64%
BBIO BuyBRIDGEBIO PHARMA INC$3,176,000
+220.5%
109,500
+286.9%
0.61%
+218.8%
BIIB NewBIOGEN INC$3,164,00010,000
+100.0%
0.61%
ZG NewZILLOW GROUP INCcall$3,057,00090,000
+100.0%
0.59%
BYND BuyBEYOND MEAT INC$2,865,000
+30.6%
43,000
+48.3%
0.55%
+29.8%
IGIC NewINTL GNRL INSURANCE HLDNGS L$2,800,000350,000
+100.0%
0.54%
DDOG NewDATADOG INC$2,641,00073,400
+100.0%
0.51%
ARVN NewARVINAS INC$2,640,00065,500
+100.0%
0.51%
TMUS NewT MOBILE US INCcall$2,517,00030,000
+100.0%
0.48%
NKE NewNIKE INCcl b$2,482,00030,000
+100.0%
0.48%
BDTX NewBLACK DIAMOND THERAPEUTICS I$2,370,00095,000
+100.0%
0.45%
ICUI NewICU MED INC$2,220,00011,000
+100.0%
0.42%
NVTA NewINVITAE CORPcall$2,051,000150,000
+100.0%
0.39%
VRTX NewVERTEX PHARMACEUTICALS INC$1,903,0008,000
+100.0%
0.36%
GILD NewGILEAD SCIENCES INCput$1,869,00025,000
+100.0%
0.36%
TEAM NewATLASSIAN CORP PLCput$1,784,00013,000
+100.0%
0.34%
RARE BuyULTRAGENYX PHARMACEUTICAL IN$1,711,000
+640.7%
38,500
+612.7%
0.33%
+628.9%
THO NewTHOR INDS INCcall$1,688,00040,000
+100.0%
0.32%
SQ NewSQUARE INCcl a$1,519,00029,000
+100.0%
0.29%
REGN NewREGENERON PHARMACEUTICALS$1,487,0003,047
+100.0%
0.28%
QTWO NewQ2 HLDGS INCput$1,477,00025,000
+100.0%
0.28%
ROST NewROSS STORES INC$1,392,00016,000
+100.0%
0.27%
ALEC NewALECTOR INCcall$1,207,00050,000
+100.0%
0.23%
FIVE NewFIVE BELOW INC$1,056,00015,000
+100.0%
0.20%
QURE BuyUNIQURE NV$1,044,000
+82.2%
22,000
+175.0%
0.20%
+80.2%
AVRO NewAVROBIO INC$942,00060,600
+100.0%
0.18%
NCLH NewNORWEGIAN CRUISE LINE HLDG Lput$658,00060,000
+100.0%
0.13%
ADSK NewAUTODESK INC$312,0002,000
+100.0%
0.06%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-05-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MARTIN MARIETTA MATLS INC38Q3 20236.1%
NETFLIX INC35Q2 20235.6%
MICROSOFT CORP32Q3 20236.7%
AMAZON COM INC29Q3 20238.6%
LIBERTY MEDIA CORP DELAWARE29Q2 20235.3%
META PLATFORMS INC25Q3 20235.8%
INTUITIVE SURGICAL INC24Q3 20233.3%
ARGENX SE23Q3 20231.6%
INSPIRE MED SYS INC22Q3 20235.1%
EPAM SYS INC22Q3 20221.8%

View Atika Capital Management LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-14
13F-HR2024-02-13
13F-HR2023-11-13
13F-HR2023-08-11
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-11

View Atika Capital Management LLC's complete filings history.

Compare quarters

Export Atika Capital Management LLC's holdings